Prof. Zhongmin Wang 王忠敏
Chief Physician, Professor
Interventional Radiology, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai
Public profile Compiled from public listings and PubMed. We do not work directly with this doctor, but we can find a specialist in this field to review your case.
Get a specialist opinionClinical focus: Minimally invasive interventional treatments for tumors, vascular diseases, and airway or digestive tract conditions. Procedures include tumor ablation, radioactive seed implantation, chemoembolization, stent placement, and vascular interventions such as TIPS and thrombolysis.
Dr. Wang holds an MD and postdoctoral degree. As a Chief Physician and professor at Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Dr. Wang specializes in interventional diagnosis and treatment. Dr. Wang helped introduce 3D-printing assistance for radioactive seed implantation in pancreatic cancer and contributed to multiple national and international expert consensus guidelines on ablation, embolization, and TIPS procedures.
Professional roles
- Vice President, Interventional Physician Branch, Chinese Medical Doctor Association
- Secretary-General, Interventional Professional Committee, Radiology Branch, Chinese Medical Association
- Vice Chair, Radiation Interventional Professional Committee, Chinese Society of Clinical Oncology (CSCO)
- Vice Chair, Tumor Ablation Professional Committee, China Anti-Cancer Association
Name order: in Chinese the family name comes first (Wang Zhongmin). Papers usually list the name as Zhongmin Wang or Wang Z.
Selected publications
88 papers on PubMed matched by name and affiliation; 18 as first or senior author since 2016. Most recent first- or senior-author papers:
- Quant Imaging Med Surg, 2025 (senior author): Endovascular intervention and risk factor assessment for postoperative pseudoaneurysms after pancreatic surgery: a 9-year retrospective study. PubMed 41209271
- Eur J Med Res, 2025 (first author): Impact of thermal ablation/cryoablation treatment on prognosis among patients with kidney cancer: a SEER database-based cohort study. PubMed 40383782
- J Cancer Res Ther, 2024 (first author): Percutaneous irreversible electroporation of renal cell carcinomas in an acquired solitary kidney: A primary study. PubMed 39792409
- Eur Radiol, 2024 (senior author): DKI can distinguish high-grade gliomas from IDH1-mutant low-grade gliomas and correlate with their different nuclear-to-cytoplasm ratio: a localized biopsy-based study. PubMed 37962597
- Front Oncol, 2024 (senior author): A retrospective study of irreversible electroporation for tumors adjacent to perihepatic important structure. PubMed 39328209
- Nat Commun, 2023 (senior author): Interventional hydrogel microsphere vaccine as an immune amplifier for activated antitumour immunity after ablation therapy. PubMed 37433774
- Clin Nurs Res, 2023 (senior author): Transitional Care for Patients With Portal Hypertension: A Multicenter Study of Intervention for Post-TIPS Patients. PubMed 36047431
- J Magn Reson Imaging, 2023 (senior author): Editorial for "LI-RADS Category on MRI Is Associated With Recurrence of Intrahepatic Cholangiocarcinoma After Surgery: A Multicenter Study". PubMed 35986651
See the full PubMed search. Automatic matching can miss papers or include a namesake at the same hospital.
This profile has not been reviewed by the doctor. How we build this directory.
Want a specialist to review your case?
Send your records. We find a specialist in this field who can review your case and write a treatment plan with a cost estimate.
Get a specialist opinion